Featured studies
High Cholesterol
This study will be recruiting patients, age 50 to 80 years.
Osteoporosis Notification Service
Were you not able to find a clinical study suitable for your needs? ClinLife will inform you as soon as we publish an osteoporosis trial. Please click on "Register for this trial" and follow the registration process:
Men with a genetic predisposition to prostate cancer
This study will be recruiting male carriers of a known pathogenic BRCA1/2 mutations or men testing negative for a known BRCA1/2 mutation in their family, aged between 40 - 69 years old.
Ulcerative Colitis
This trail will be recruiting patients, both gender, age 18 - 99, with the diagnosis "Ulcerative Colitis".
Alzheimer Notification Service
Were you not able to find a clinical study suitable for your needs?ClinLife will inform you as soon as we publish an Alzheimer's disease trial. Please click on "Register for this trial" and follow the registration process:
Parkinson's Disease Notification Service
Were you not able to find a clinical study suitable for your needs? ClinLife will inform you as soon as we publish a Parkinson's disease trial. Please click on "Register for this trial" and follow the registration process:
Epilepsy Notification Service
Were you not able to find a clinical study suitable for your needs? ClinLife will inform you as soon as we publish an epilepsy trial. Please click on "Register for this trial" and follow the registration process:
Sleep Disorder Notification Service
Were you not able to find a clinical study suitable for your needs? ClinLife will inform you as soon as we publish a sleep disorder trial. Please click on "Register for this trial" and follow the registration process:
Obesity Notification Service
Were you not able to find a clinical study suitable for your needs? ClinLife will inform you as soon as we publish an obesity trial. Please click on "Register for this trial" and follow the registration process:
Type 2 Diabetes Study
This trial will be recruiting healty volunteers, both gender, age 25 - 75 to test whether screening for diabetes is feasible in a South Asian population and to measure the benefits of early detection and intensive treatment.
